Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Pharmaron Beijing Debt to Equity Ratio : 0.4253 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4253 |
| March 31, 2026 | 0.4314 |
| December 31, 2025 | 0.4674 |
| September 30, 2025 | 0.4372 |
| June 30, 2025 | 0.4263 |
| March 31, 2025 | 0.4243 |
| December 31, 2024 | 0.4388 |
| September 30, 2024 | 0.4362 |
| June 30, 2024 | 0.4452 |
| March 31, 2024 | 0.6575 |
| December 31, 2023 | 0.7723 |
| September 30, 2023 | 0.5459 |
| June 30, 2023 | 0.5291 |
| March 31, 2023 | 0.5718 |
| December 31, 2022 | 0.6119 |
| September 30, 2022 | 0.5443 |
| June 30, 2022 | 0.5385 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.5289 |
| December 31, 2021 | 0.5239 |
| September 30, 2021 | 0.5273 |
| June 30, 2021 | 0.5372 |
| March 31, 2021 | 0.152 |
| December 31, 2020 | 0.1237 |
| September 30, 2020 | 0.0652 |
| June 30, 2020 | 0.0564 |
| March 31, 2020 | 0.0379 |
| December 31, 2019 | 0.1432 |
| September 30, 2019 | 0.5384 |
| June 30, 2019 | 0.5338 |
| March 31, 2019 | 0.5553 |
| December 31, 2018 | 0.7086 |
| September 30, 2018 | 0.6748 |
| June 30, 2018 | 0.7189 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 0.376 |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 1.167 |
| SPO Global, Inc. | -0.9478 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.294B |
| Total Liabilities (Quarterly) | 1.715B |
| Shareholders Equity (Quarterly) | 2.409B |
| Current Ratio | 1.017 |
| Net Debt Paydown Yield | -1.15% |